Get the Stockscreener App
239.13
0.77%
+1.83
Cencora Inc stock is currently priced at $239.13, with a 24-hour trading volume of 1.28M.
It has seen a +0.77% increased in the last 24 hours and a -1.33% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $237.4 pivot point. If it approaches the $239.3 resistance level, significant changes may occur.
Cencora Inc Stock (COR) Financials Data
Cencora Inc (COR) Revenue 2024
COR reported a revenue (TTM) of $271.58 billion for the quarter ending December 31, 2023, a +12.31% rise year-over-year.
Cencora Inc (COR) Net Income 2024
COR net income (TTM) was $1.87 billion for the quarter ending December 31, 2023, a +7.96% increase year-over-year.
Cencora Inc (COR) Cash Flow 2024
COR recorded a free cash flow (TTM) of $3.63 billion for the quarter ending December 31, 2023, a +76.41% increase year-over-year.
Cencora Inc (COR) Earnings per Share 2024
COR earnings per share (TTM) was $9.18 for the quarter ending December 31, 2023, a +11.41% growth year-over-year.
Cencora Inc Stock (COR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| COLLIS STEVEN H | Chairman, President & CEO |
Apr 16 '24 |
Option Exercise |
89.58 |
10,754 |
963,343 |
295,842 |
| COLLIS STEVEN H | Chairman, President & CEO |
Apr 16 '24 |
Sale |
237.48 |
10,754 |
2,553,860 |
285,088 |
| Mauch Robert P. | Executive Vice President & COO |
Apr 15 '24 |
Option Exercise |
89.58 |
33,877 |
3,034,702 |
81,976 |
| Mauch Robert P. | Executive Vice President & COO |
Apr 15 '24 |
Sale |
235.09 |
57,564 |
13,532,721 |
24,412 |
| COLLIS STEVEN H | Chairman, President & CEO |
Mar 19 '24 |
Option Exercise |
89.58 |
10,755 |
963,433 |
295,843 |
| COLLIS STEVEN H | Chairman, President & CEO |
Mar 19 '24 |
Sale |
240.21 |
10,755 |
2,583,459 |
285,088 |
| Campbell Elizabeth S | Executive Vice President |
Mar 18 '24 |
Sale |
238.12 |
6,977 |
1,661,363 |
8,246 |
| Clark Gina | Executive Vice President |
Feb 13 '24 |
Sale |
230.48 |
1,100 |
253,528 |
24,802 |
| Walgreens Boots Alliance, Inc. | 10% Owner |
Feb 07 '24 |
Sale |
235.41 |
4,212,395 |
991,639,907 |
26,277,561 |
| GREENBERG LON R | Director |
Jan 15 '24 |
Option Exercise |
219.43 |
1,340 |
294,036 |
26,219 |
Cencora Inc Stock (COR) Latest News
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Zacks Investment Research
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
Zacks Investment Research
GE HealthCare's (GEHC) Voluson to Aid Women's Health Imaging
Zacks Investment Research
Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust
Zacks Investment Research
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
Zacks Investment Research
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Zacks Investment Research
About Cencora Inc
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
COMPANY PROFILE
NameCencora Inc
SectorHealthcare (1201)
IndustryMedical Distribution (11)
Webcencora.com
Phone(610) 727-7000
Employee46,000
Next earning date2024-05-01
Address1 WEST FIRST AVENUE, CONSHOHOCKEN, USA (19428)
1.16%
Cap:
|
Volume (24h):